Cerenkov luminescence imaging for radiation dose calculation of a ⁹⁰Y-labeled gastrin-releasing peptide receptor

Keyphrases

• Gastrin-releasing Peptide Receptor (GRPr) 100%
• Cerenkov Luminescence Imaging 100%
• Radiation Dose Assessment 100%
• Radiation Dose 50%
• Activity Concentration 50%
• Tumor 37%
• After Injection 37%
• Gastrin-releasing Peptide Receptor Antagonist 37%
• Kidney 25%
• Prostate Cancer 25%
• Injected Activity 25%
• Labeled Compounds 25%
• Mouse Model 12%
• Tumor Model 12%
• New Therapeutics 12%
• Positron Emission 12%
• Nude Mice 12%
• Renal Activity 12%
• Low Abundance 12%
• Targeted Radiotherapy 12%
• Time-activity Curve 12%
• Tumor Activity 12%
• Cerenkov Luminescence 12%
• Cancer Xenograft 12%
• Radioactivity Concentration 12%
• Photon Counting 12%
• In Vivo Images 12%
• Therapeutic Radiopharmaceuticals 12%
• Conversion Factor 12%
• Cerenkov Photons 12%
• Liquid Scintillation Counting 12%

Pharmacology, Toxicology and Pharmaceutical Science

• Yttrium 90 100%
• Gastrin Releasing Peptide Receptor 100%
• Neoplasm 50%
• Receptor Antagonist 37%
• Prostate Cancer 25%
• Tetraxetan 25%
• Mouse Model 12%
• Nude Mouse 12%
• Radiopharmaceutical Agent 12%
• Tumor Model 12%

Neuroscience

• In Vivo 100%
• Gastrin-Releasing Peptide Receptor 100%
• Receptor Antagonist 60%
• Radiation Therapy 20%
• Radiopharmaceutical 20%